These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 970168)

  • 21. [N1-aryl-N1-alkyl(or acetamido)-N4-arylsulfonyl-semicarbazides of potential hypoglycemic activity].
    Brancaccio G; Lettieri G; Larizza A; Monforte P
    Boll Chim Farm; 1979 May; 118(5):261-5. PubMed ID: 454545
    [No Abstract]   [Full Text] [Related]  

  • 22. Preparation and antidiabetic activity of some sulfonylurea derivatives of 3,5-disubstituted pyrazoles.
    Soliman R
    J Med Chem; 1979 Mar; 22(3):321-5. PubMed ID: 423216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypoglycemic compounds. Sulfanilylurea derivatives containing amino acids and dipeptides. I.
    Vicentini CB; Guarneri M; Sarto G
    Farmaco Sci; 1983 Aug; 38(8):595-602. PubMed ID: 6617854
    [No Abstract]   [Full Text] [Related]  

  • 24. Preparation and antidiabetic activity of new substituted 3,5-diarylpyrazolesulfonylurea derivatives.
    Soliman R; Feid-Allah HM; El Sadany SK; Mohamed HF
    J Pharm Sci; 1981 Jun; 70(6):606-10. PubMed ID: 6788935
    [No Abstract]   [Full Text] [Related]  

  • 25. Synthesis and antidiabetic activity of some sulfonylurea derivatives of 3,5-disubstituted pyrazoles.
    Soliman R; Mokhtar H; Mohamed HF
    J Pharm Sci; 1983 Sep; 72(9):999-1004. PubMed ID: 6631713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and antidiabetic activity of some sulfonylurea derivatives of 3,4,5-trisubstituted pyrazoles.
    Soliman R; Mokhtar H; Mohamed HF
    J Pharm Sci; 1983 Sep; 72(9):1004-7. PubMed ID: 6631680
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biotransformation of a new hypoglycemic agent, N-(p-toluenesulfonyl)-5-methyl-2-pyrazoline-1-carbonamide (SPC-703) in humans and rats.
    Jakubowski Z; Angielski S
    Pol J Pharmacol Pharm; 1980; 32(1):37-46. PubMed ID: 7454610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and biological evaluation of sulfonylurea and thiourea derivatives substituted with benzenesulfonamide groups as potential hypoglycemic agents.
    Zhang HB; Zhang YA; Wu GZ; Zhou JP; Huang WL; Hu XW
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1740-4. PubMed ID: 19216076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and blood glucose lowering effect of novel pyridazinone substituted benzenesulfonylurea derivatives.
    Rathish IG; Javed K; Bano S; Ahmad S; Alam MS; Pillai KK
    Eur J Med Chem; 2009 Jun; 44(6):2673-8. PubMed ID: 19171410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New oral antidiabetic drugs. Synthesis and structure-activity relationships.
    Francia E; Marin A; Verdejo F; Sanchez MS; Morell J
    Boll Chim Farm; 1975 Jul; 114(7):379-92. PubMed ID: 1164447
    [No Abstract]   [Full Text] [Related]  

  • 31. The action of a sulfonylurea hypoglycemic agent (orinase) in extrahepatic tissues.
    BRITTON B; GRABOWSKI R; WICK AN
    Metabolism; 1956 Nov; 5(6 Part 2):739-43. PubMed ID: 13378041
    [No Abstract]   [Full Text] [Related]  

  • 32. Derivatives of 4,5,6,7-tetrahydro-7,8,8-trimethyl-3-phenylamino-4,7-methano-2H-ind azo le with hypotensive and hypoglycemic activities. II.
    Ranise A; Bondavalli F; Schenone P; Lampa E; Greco R; Scafuro M; Marmo E
    Farmaco Sci; 1984 Mar; 39(3):200-7. PubMed ID: 6714414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mass spectrometric identification of the thermal decomposition products of N-(p-toluenesulfonyl)-N'-(aza-bicyclo-(3.3.0.) octyl) urea (S-852).
    Belvedere G; Fanelli R; FrigerioA ; Malen E; Hugon P
    J Chromatogr Sci; 1975 Jan; 13(1):51-6. PubMed ID: 1117049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stoichiometry of calcium binding by hypoglycemic sulfonylureas.
    Deleers M; Brasseur R; Malaisse WJ
    Res Commun Chem Pathol Pharmacol; 1983 Nov; 42(2):181-201. PubMed ID: 6658185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sulfamylurea hypoglycemic agents. 6. High-potency derivatives.
    Sarges R; Kuhla DE; Wiedermann HE; Mayhew DA
    J Med Chem; 1976 May; 19(5):695-709. PubMed ID: 1271411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New potential antihistaminic compounds. Virtual combinatorial chemistry, computational screening, real synthesis, and pharmacological evaluation.
    Duart MJ; Antón-Fos GM; Alemán PA; Gay-Roig JB; González-Rosende ME; Gálvez J; García-Domenech R
    J Med Chem; 2005 Feb; 48(4):1260-4. PubMed ID: 15715494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intrapancreatic perfusion of the antidiabetic sulfonylureas.
    COLWELL AR; COLWELL AR; COLWELL JA
    Metabolism; 1956 Nov; 5(6 Part 2):749-56. PubMed ID: 13378043
    [No Abstract]   [Full Text] [Related]  

  • 38. Synthesis, characterization and in vitro antimicrobial activity of novel sulfonylureas of 15-membered azalides.
    Krajacić MB; Kujundzić N; Dumić M; Cindrić M; Brajsa K; Metelko B; Novak P
    J Antibiot (Tokyo); 2005 Jun; 58(6):380-9. PubMed ID: 16156514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. N-substituted urethanes as potential antiinflammatory agents.
    Krupińska J; Piotrowicz J; Cebo E; Stypuła K; Bronisz S; Bobrański B; Stankiewicz K
    Farmaco Sci; 1985 Aug; 40(8):581-8. PubMed ID: 3876240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical experimentation with a new hypoglycemic agent (glipizide)].
    Forattini C
    Minerva Med; 1972 Oct; 63(70):3816-21. PubMed ID: 4562437
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.